DCK and acute myeloid leukemia: Our findings are consistent with previous reports showing that reduced hENT1 and dCK expression, together with increased SIRT1 levels, plays a critical role in the development and maintenance of cytarabine resistance in AML cell lines and patient samples [11,13,21,37,46].